CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence

REFERENCES

• Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, et al.: Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev 9, 1059–1065, 2000.
   PubMed Web of Science ®Google Scholar
• Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, et al.: Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 39, 35–41, 2001. doi:10.1207/S15327914nc391_5
   PubMed Web of Science ®Google Scholar
• Takahashi R, Mizoue T, Otake T, Fukumoto J, Tajima O, et al.: Circulating vitamin D and colorectal adenomas in Japanese men. Cancer Sci 101, 1695–1700, 2010. doi:10.1111/j.1349-7006.2010.01575.x
   PubMed Web of Science ®Google Scholar
• Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, et al.: Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer 63, 319–326, 2011. doi:10.1080/01635581.2011.535960
   PubMed Web of Science ®Google Scholar
• Zheng XE, Lipka S, Li T, Shahzad G, Levine E, et al.: The relationship of vitamin D status, smoking, and colorectal adenoma: A retrospective study in an ethnically diverse community. J Steroid Biochem Mol Biol 136, 280–283, 2013. doi:10.1016/j.jsbmb.2012.09.018
   PubMed Web of Science ®Google Scholar
• LePane CAS, Singh G, Spanier-Stiasny JA, Svinarich DM,; Rasansky RJ, et al.: Implications of serum 25-Hydroxyvitamin D on the prevalence of neoplastic polyps: A cross-sectional study. Gastroenterology Res 4, 43–50, 2011.
   PubMedGoogle Scholar
• Yin L, Grandi N, Raum E, Haug U, Arndt V, et al.: Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med 53, 10–16, 2011. doi:10.1016/j.ypmed.2011.05.013
   PubMed Web of Science ®Google Scholar
• Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, et al.: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. International Journal of Cancer/Journal international du cancer 128, 1414–1424, 2011. doi:10.1002/ijc.25439
   PubMed Web of Science ®Google Scholar
• Wei MY, Garland CF, Gorham ED, Mohr SB, and Giovannucci E: Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17, 2958–2969, 2008. doi:10.1158/1055-9965.EPI-08-0402
   PubMed Web of Science ®Google Scholar
• Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, et al.: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128, 1414–1424, 2011.
   PubMed Web of Science ®Google Scholar
• Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, et al.: Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 32, 210–216, 2007. doi:10.1016/j.amepre.2006.11.004
   PubMed Web of Science ®Google Scholar
• Yin L, Grandi N, Raum E, Haug U, Arndt V, et al.: Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30, 113–125, 2009. doi:10.1111/j.1365-2036.2009.04022.x
   PubMed Web of Science ®Google Scholar
• Holick M: Vitamin D. In: Modern Nutrition in Health and Disease. Baltimore, MD: Williams and Wilkins 1999, pp. 329–345.
   Google Scholar
• Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, et al.: Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54, 805–810, 1994.
   PubMed Web of Science ®Google Scholar
• Frampton RJ, Omond SA, and Eisman JA: Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 43, 4443–4447, 1983.
   PubMed Web of Science ®Google Scholar
• Giuliano AR, Franceschi RT, and Wood RJ: Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285, 261–269, 1991.
   PubMed Web of Science ®Google Scholar
• Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, et al.: 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53, 3712–3718, 1993.
   PubMed Web of Science ®Google Scholar
• Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, et al.: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154, 369–387, 2001.
   PubMed Web of Science ®Google Scholar
• Wong NA and Pignatelli M: Beta-catenin—a linchpin in colorectal carcinogenesis? Am J Pathol 160, 389–401, 2002.
   PubMed Web of Science ®Google Scholar
• Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, et al.: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13, 1502–1508, 2004.
   PubMed Web of Science ®Google Scholar
• Hibler EA, Sardo Molmenti CL, Lance P, Jurutka PW, and Jacobs ET: Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control 25, 809–817, 2014. doi:10.1007/s10552-014-0382-6
   PubMed Web of Science ®Google Scholar
• Deeb KK, Trump DL, and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7, 684–700, 2007. doi:10.1038/nrc2196
   PubMed Web of Science ®Google Scholar
• Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, et al.: CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res 73, 2563–2573, 2013. doi:10.1158/0008-5472.CAN-12-4134
   PubMed Web of Science ®Google Scholar
• Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al.: Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180–188, 2010. doi:10.1016/S0140-6736(10)60588-0
   PubMed Web of Science ®Google Scholar
• McGrath JJ, Saha S, Burne TH, and Eyles DW: A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. J Steroid Biochem Mol Biol 121, 471–477, 2010. doi:10.1016/j.jsbmb.2010.03.073
   PubMed Web of Science ®Google Scholar
• Signorello LB, Shi J, Cai Q, Zheng W, Williams SM, et al.: Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS One 6, e28623, 2011. doi: 10.1371/journal.pone.0028623
   PubMed Web of Science ®Google Scholar
• Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, et al.: Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 22, 2037–2046, 2013. doi:10.1158/1055-9965.EPI-13-0209
   PubMed Web of Science ®Google Scholar
• Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, et al.: Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 18, 2540–2548, 2009. doi:10.1158/1055-9965.EPI-09-0228
   PubMed Web of Science ®Google Scholar
• Mahmoudi T, Karimi K, Arkani M, Farahani H, Nobakht H, et al.: Lack of associations between Vitamin D metabolism-related gene variants and risk of colorectal cancer. Asian Pac J Cancer Prev 15, 957–961, 2014.
   PubMed Web of Science ®Google Scholar
• Pibiri F, Kittles RA, Sandler RS, Keku TO, Kupfer SS, et al.: Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control 25, 561–570, 2014. doi:10.1007/s10552-014-0361-y
   PubMed Web of Science ®Google Scholar
• Alberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, et al.: Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97, 846–853, 2005. doi:10.1093/jnci/dji144
   PubMed Web of Science ®Google Scholar
• Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, et al.: Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342, 1156–1162, 2000. doi:10.1056/NEJM200004203421602
   PubMed Web of Science ®Google Scholar
• Block G, Hartman AM, and Naughton D: A reduced dietary questionnaire: development and validation. Epidemiology 1, 58–64, 1990.
   PubMedGoogle Scholar
• Hollis BW: Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282, 174–186, 1997.
   PubMed Web of Science ®Google Scholar
• Hollis BW: Assessment of circulating 25(OH)D and 1,25(OH)2D: emergence as clinically important diagnostic tools. Nutr Rev 65, S87–S90, 2007.
   PubMed Web of Science ®Google Scholar
• Ross CAT, C.A.; Yaktine, K.L.; Del Valle, H.B.: Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.
   Google Scholar
• R Core Team R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2012. Retrieved from http://www.R-project.org/
   Google Scholar
• Jacobs ET, Hibler EA, Lance P, Sardo CL, and Jurutka PW: Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer 133, 2980–2988, 2013.
   PubMed Web of Science ®Google Scholar
• Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, et al.: Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22, 709–716, 2012.
   PubMed Web of Science ®Google Scholar
• Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, et al.: Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365, 410–421, 2011. doi:10.1056/NEJMoa1103864
   PubMed Web of Science ®Google Scholar
• Azad AK, Bairati I, Qiu X, Huang H, Cheng D, et al.: Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer 132, 2520–2527, 2013. doi:10.1002/ijc.27946
   PubMed Web of Science ®Google Scholar
• Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, et al.: Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med 41, 779–787, 2012. doi:10.1111/j.1600-0714.2012.01164.x
   PubMed Web of Science ®Google Scholar
• Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, et al.: Vitamin D pathway gene variants and prostate cancer prognosis. Prostate 70, 1448–1460, 2010. doi:10.1002/pros.21180
   PubMed Web of Science ®Google Scholar
• Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al.: Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88, 441–447, 2008.
   PubMed Web of Science ®Google Scholar
• Hypponen E, Berry DJ, Wjst M, and Power C: Serum 25-hydroxyvitamin D and IgE: a significant but nonlinear relationship. Allergy 64, 613–620, 2009. doi:10.1111/j.1398-9995.2008.01865.x
   PubMed Web of Science ®Google Scholar
• Ramos-Lopez E, Kahles H, Weber S, Kukic A, Penna-Martinez M, et al.: Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes Metab 10, 683–685, 2008. doi:10.1111/j.1463-1326.2008.00879.x
   PubMed Web of Science ®Google Scholar
• Jacobs ET, Hibler EA, Lance P, Sardo CL, and Jurutka PW: Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer 133, 2980–2988, 2013. doi:10.1002/ijc.28316
   PubMed Web of Science ®Google Scholar
• Wjst M, Altmuller J, Faus-Kessler T, Braig C, Bahnweg M, et al.: Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respiratory Research 7, 60, 2006. doi:10.1186/1465-9921-7-60
   PubMed Web of Science ®Google Scholar
• Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, et al.: Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes & Control 23, 1017–1029, 2012. doi:10.1007/s10552-012-9967-0
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information: Database of Single Nucleotide Polymorphisms (dbSNP, Build ID: 137). Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine, 2012.
   Google Scholar